Leptospirosis presenting as ascending progressive leg weakness and complicating with acute pancreatitis  by Silva, Andre Pacheco et al.
493
Leptospirosis presenting as ascending progressive  








1Resident Physicians in 
Internal Medicine, Hospital 
Universitário, Universidade 
Federal de Santa Catarina 
(UFSC), SC, Brazil 
2Specialist in Clinical 
Gastroenterology; 
Postgraduate in Hepatology 
focused on Hepatic 
Transplantation; Emergency 
Physician at Hospital 
Universitário, UFSC; Preceptor 
Physician for the Internal 
Medicine Residency Program 
at Hospital Universitário, 
UFSC; Member of the Câmara 
Técnica de Transplante de 
Fígado do Estado de Santa 
Catarina; Physician, Imperial 
Hospital de Caridade, 
Florianópolis, SC, Brazil 







Universidade Federal de 
Santa Catarina
Departamento de Clínica 
Médica
Rua Profª Maria Flora 
Pausewang, Sn Trindade
88040-900 - Florianopolis, 
SC, Brazil
andreps_garopaba@yahoo.com.br
We declare no conflict of 
interest.
©2011 Elsevier Editora Ltda. 
ABSTRACT
Leptospirosis is a spirochetal bacterial infection of great public health importance. It has a broad 
spectrum of clinical manifestations which goes from subclinical infection and self-limited anicteric 
febrile illness (80-90% of all cases) to icteric leptospiropirosis known as Weil’s disease. This is a 
severe disease characterized by hemorrhage, acute renal failure and jaundice. It is uncommon for 
leptospirosis to present itself as a primary neurological disease. Additionally, acute pancreatitis is 
an unusual gastrointestinal manifestation. We report a case of leptospirosis presenting as ascending 
progressive leg weakness and complicating with acute pancreatitis in an adult patient treated at 
Hospital Universitário, Universidade Federal de Santa Catarina. The diagnosis was confirmed 
through ELISA-IgM antibody testing positive for leptospirosis. After antibiotic therapy and support 
treatment for a few weeks, total resolution of severe manifestations was achieved. Rare and unusual 
presentations of leptospirosis should be kept in mind in relevant epidemiological scenario.
Keywords: leptospirosis; pancreatitis; neurologic manifestations.
limited anicteric febrile illness (80-90% of all 
cases) to icteric leptospiropirosis known as 
Weil’s disease, a severe and potentially fatal 
disease characterized by hemorrhage, acute 
renal failure and jaundice.2 
It is uncommon for leptospirosis to pre- 
sent as a primary neurological disease. Both 
central and peripheral neurological manifesta-
tions of the disease may be seen, but usually in 
context of advanced infection, where the diag-
nosis has already been established.5 The com-
monest neurological manifestation is aseptic 
meningitis.6 Peripheral nerve involvement is 
rare, but abnormalities reported include tran-
sient lower limb weakness, areflexia, paraes-
thesiae, neuropathies and the Guillain-Barré 
syndrome (GBS). There are a few cases of GBS-
like presentation during or following infection 
with Leptospira interrogans documented in the 
literature.5,7,8
Acute pancreatitis is an uncommon gas-
trointestinal manifestation of leptospirosis. 
There are considerable number of cases doc-
umented in literature, but the involvement 
of the pancreas is not yet well understood 
in human leptospirosis.8-21 The diagnosis of 
INTRODUCTION
Leptospirosis is a worldwide spirochetal bacterial 
infection of great public health importance in 
the tropics. The source of infection in humans 
is usually either direct or indirect contact with 
the urine of infected animals. These bacteria 
infect humans by entering through abraded 
skin, mucous membrane, conjunctivae.1,2 It is 
an endemic disease in several regions of Brazil, 
more often due to bad living conditions and 
seasonal floodings, seen in the rainy seasons.3 
After an incubation period of 1-2 weeks, 
leptospirosis manifests as a biphasic illness with 
the leptospiremic phase followed by an immune 
phase.4 
This disease is characterized by the de-
velopment of vasculitis, endothelial damage, 
and inflammatory infiltration. Leptospirosis 
mostly affects tissues of the liver and 
kidney. Rarely, other organs such as brain, 
pancreas, lung, heart, gallbladder, brain, and 
ophthalmic tissues are involved, mainly due 
to vasculitis.1,2 Clinically, it shows a broad 
spectrum of clinical manifestations which 
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acute pancreatitis may be complicated as acute renal fail-
ure can increase the serum amylase and lipase levels.10,19,22
We report a case of leptospirosis presenting as ascend-
ing progressive leg weakness and complicating with acute 
pancreatitis in an adult patient seen at a tertiary care cen-
tre in Florianópolis. Medical records of this patient were 
retrospectively reviewed in praparation of the case.
CASE REPORT
A 48-year-old black male patient from southeast of Brazil 
was admitted in the emergency department of our hospital 
on the October 16th, 2010. At the time, he was working as a 
plumber in south of Brazil. He presented with complaints 
of progressive loss of strength and severe pain in both legs 
with four-day history. Previously to that, he reported being 
healthy and did not present any other known diseases. He 
also complained about a high grade fever and a bilateral 
headache, mainly occipital, of moderate intensity, in the 
past three days. One day after the appearance of the fever, 
he started with diarrhea, without fecal incontinence, 
abdominal pain, blood or pathological products. Urine 
alterations or urinary retention were not observed. On 
the day before being admitted to the hospital, he presented 
difficulty to stand up due to severe pain and loss of 
movement control on both legs. He referred 4-kg weight loss 
in the last week. He denied contact with jaundiced persons, 
blood transfusion and drug abuse, except for small amount 
of alcohol daily intake. He had contact with contaminated 
water 1-2 weeks before coming to the hospital. 
On physical examination, he was in poor condi-
tion, dehydrated, oriented, anicteric, pulse rate 108 bpm 
and temperature of 39.1°C. Blood pressure was 
140 x 80 mmHg with no dyspnea and with normal car-
dio-pulmonar and abdominal auscultation. His abdomen 
was flat, flaccid, and there was no hepatomegaly. The 
neurological examination disclosed paraparesis, Muscle 
Research Council (MRC) grade 2 strength in both legs, 
and painful skin upon touch. The patellar and ankle re-
flexes were absent. Strength was normal in upper limbs, 
biceps and flexor reflexes were normal. Sensibility was 
preserved. He did not present nuchal rigidity, exam of 
cranial nerves was normal and no other abnormalities 
were noticed. Autonomic dysfunctions, loss of sphincter 
control or swallowing disorders were not observed. 
Laboratory findings on admission revealed Hb: 
12.8 g/dL ; Htc: 37.6% ; WBC: 6770/mm3; platelet count: 
41,000/mm3 (n: 150 x 10³ – 440 x 10³); creatinine: 
1.3 Mg/dL (n: 0.8-1.3); Na: 132 mEq/L (n: 136-145); aspar- 
tate transaminase: 213 U/L (n: 15-37); alanine transam-
inase: 130 U/L (n: 25-64); alkaline phosphatase: 
109 U/L (n: 50-136); gamma glutamyltransferase: 106 U/L 
(n: 15-85); total bilirrubin, serum K, creatine kinase were 
normal; serology negative for viral hepatitis and HIV. 
A lumbar puncture was performed on the fourth day 
of initial symptoms, and cerebrospinal fluid (CSF) was 
clear. CSF glucose and protein were normal, latex tests for 
cryptococcal antigen was negative, and no bacteria were 
found. B12 vitamin level and thyroid function were nor-
mal. Chest X-ray was normal.
On the admission day, the patient was put on intravenous 
hydration and received thiamine and medication for 
symptom relief. One day after being admitted to the 
hospital jaundice and severe abdominal pain ensued, and 
the patient remained presenting paraparesis and severe 
pain in both legs. A neurologic evaluation was requested 
and performed by a neurologist, who noted loss of strength 
not only restricted to legs, but also a paresis on upper limbs, 
MRC grade 4, biceps, triceps and supinator hyporeflexia. 
GBS was thought to be the main cause. 
On the second day in hospital, the urinanalysis showed 
moderate quantity of bacteria with 160 x 10³ leukocytes. 
Ceftriaxone was administered on the suspicion of uri-
nary tract infection. At that moment, the amylase evalu-
ation turned out 478 U/L (n: 25-115); lipase 898 U/L 
(n: 114-286) and creatinine: 4.9. Acute pancreatitis was 
diagnosed. No hemodialysis was necessary at that moment.
By the third day he continued with high grade fever and 
the jaundice was more evident. Total bilirrubin increased 
to 11.05 mg/dL (direct bilirubin: 10.32). Creatine kinase 
increased to 413 U/L, as shown in Table 1. Uroculture 
was normal. Ceftriaxone was discontinued and treatment 
with penicillin G started as leptospirosis infection was the 
likely diagnosis. The patient’s blood pressure dropped to 
80 x 50 mmHg and capillary refill time was decreased. Af-
ter rapid hydration he recovered his normal blood pressure 
with no vasopressors needed.
By the eighth day of initial symptoms, ELISA-IgM anti-
body testing for leptospirosis was performed.
An echocardiogram showed mild hypokinesia on left 
ventricle, ejection fraction of 49% and moderate diastol-
ic dysfunction. However, the patient has never presented 
dyspnea during his clinical evolution. Abdominal ultra-
sonography showed free peritoneal fluid and abdomen 
CT-Scan showed free fluid in the pelvis and bilateral pleu-
ral effusion. Nothing was observed at the pancreas site. 
The therapy with penicillin was continued. On the 
following days, the neurological symptoms presented 
progressive improvement. A mild improvement on la-
boratory findings was also noted. From hospital day 6 on 
the patient did not present fever, headache or diarrhea, 
although he remained icteric. His creatinine level 
gradually returned to normal levels. 
The neurological findings remained unchanged until 
the 6th day, when a gradual daily improvement was ob-
served. Spinal cord magnetic resonance imaging (MRI) 
and eletrophysiologic studies were not performed due to 
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the improvement of clinical findings with the introduction 
of leptospirosis treatment and due to financial constraints.
On hospital day 15 there was a total neurologic 
recovery and the patient was able to stand up and walk 
normally. His amylase and lipase were kept high (332 
and 706 U/L, respectively) and total bilirubin was 
2.49 (direct bilirubin: 2.23), as shown in Table 1. The 
patient was discharged on the 22nd day after admis-
sion, with a positive result for the immunoenzimatic 
ELISA-IgM antibody testing for leptospirosis (from Cen-
tral Laboratory of Public Health of Santa Catarina). He 
was asymptomatic but remained with high levels of am-
ylase and lipase. Appropriate advice for follow-up after 
30 days was given. On November 30th 2010 the patient did 
not have any complaints or weaknesses.
DISCUSSION
Leptospirosis has protean manifestations and rare and unu-
sual presentations should be kept in mind in relevant epide-
miological scenario.23
Neurological involvement in leptospirosis is rare. The 
neurological manifestations result from the effect of 
the organism on the central nervous system (CNS) and 
the host immune reaction to the organism. Following 
infection, leptospires reach the CNS rapidly. Changes in 
CSF content are a later manifestation, and it has therefore 
been suggested that some of the inflammatory neuro-
logical manifestations of leptospirosis result not from the 
organism itself but from the antibody reaction to it.5,8 The 
prognosis after primary neuroleptospirosis is generally 
good but altered sensorium and seizures herald a worse 
prognosis.6
The striking feature of this case was initial presentation 
of leptospirosis with neurological symptoms. In the 
immune phase of the illness as aseptic meningitis is 
common, with up to 90% of cases having CSF pleocytosis. 
About half of these cases have symptoms of meningeal 
irritation.6,7 However, these features are usually incidental 
to an established and generalized illness. Opposite to the 
reported in this case, the majority of florid neurological 
features seen usually occur when the diagnosis has already 
been made and treatment is in progress.5
The present case had a notably symmetric ascending 
polyneuropathy and arreflexia as initial symptoms, in 
the absence of sensory loss and sphincter disorders. The 
probable cause was meningeal and radicular inflammation 
as a result of antibody production. The neurological 
picture was progressive and reminiscent of GBS, illness 
characterized by areflexic motor paralysis with mild 
sensory involvement and typical acellular rise in CSF 
total protein.7 No typical albuminocytologic dissociation 
was found, probably because of the time of evaluation 
(4th day after onset of symptoms). In patients with GBS, 
normal CSF protein is found in about one-third of 
patients when tested earlier than one week after symptom 
onset.24 The diagnosis of GBS is confirmed when there 
Silva, Burg, Locatelli et al.
Table 1. Laboratory findings of reported patient during hospitalization, Florianópolis – SC, 2010
Test 16/10 18/10 19/10 29/10 06/11 Reference value
Hemoglobin	(g/dL)	 12.8	 12	 10.8	 	 10.4	 13.5-18
Hematocrit	(%)	 37.6	 35.2	 31.8	 	 31.9	 40-52
Leukocytes (cells/mm3)	 6,770	 7,860	 8,480	 	 5,150	 3,800-11,000
Platelets (cells/mm3)	 41,000	 22,000	 39,000	 	 562,000	 150,000-400,000
Urea (mg/dL) 45 149 141 34 36 15-39
Creatinine	(mg/dL)	 1.3	 4.9	 3.5	 1.2	 1,1	 0.8-1.3
Alanine aminotransferase (U/L) 213  142  83 25-64
Aspartate	aminotransferase	(U/L)	 130	 	 97	 	 138	 15-37
Alkaline	phosphatase	(U/L)	 109	 137	 118	 	 158	 50-136
Glutamyltransferase	(U/L)	 106	 362	 287	 	 131	 15-85
Total	bilirrubin	(mg/dL)	 0.67	 	 11.05	 	 2.42	 0-1
Direct	bilirrubin	(mg/dL)	 	 	 10.32	 	 2.28	 0-0.03
Amylase (U/L)  478 417 357 276 25-115
Lipase	(U/L)	 	 898	 647	 808	 364	 114-286
Creatine kinase (U/L) 119  413  95 35-232
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are compatible clinical features and neurological exam 
associated with typical CSF and eletrophysiologic studies. 
MRI is usually helpful in excluding acute myelopathy as 
a differential diagnosis. Eletrophysiologic tests and MRI 
were not performed in this patient because improvement 
of neurological alterations with the treatment for 
leptospirosis and due to financial constraints.
An epidemiological suspicion, a history of fever, 
headache, mialgias, low platelet count and acute renal 
dysfunction were compatible with leptospirosis. The 
diagnosis was confirmed later by ELISA-IgM antibody 
testing, which supported the presumption that neuropathy 
was triggered by an acute leptospiral infection. A total 
recovery after antibiotic therapy in this patient also 
confirmed that infection. Elisa-IgM antibody testing is 
an immunoenzimatic assay with good sensitivity and 
specificity, mainly after the 7th day of symptom onset. 
GBS has been reported as sequelae to several infections 
including Campylobacter jejuni gastroenteritis, and 
infections due to Epstein-Barr virus and cytomegalovi-
rus. Other cases occur on a background of Hodgkin’s 
disease, systemic lupus erythematous, and lymphoma. 
Although its pathogenesis is not clear, GBS may be 
induced by molecular mimicry, toxin, or immune de-
regulation. However, immunological studies delineating 
the mechanism for neuropathy triggered by Leptospira 
have not been carried out probably because of the rare 
association.7
Munford et al.5 also described a dramatic neurological 
presentation with a rapidly evolving flaccid paraplegia 
associated with biochemical evidence of renal and 
hepatic dysfunction, a fatal case in a 64-year old farm 
worker. Other authors reported cases of GBS following 
an infection with Leptospira icterohaemorrhagiae in a 
65-year old woman and in a pediatric patient.7,8
A definite relationship between an infection episode 
and neuropathy is difficult to establish as in most cases 
it is not possible to isolate the causative organism 
by the time neuropathy appears. The diagnosis is usually 
ascertained on the basis of relevant serological tests.5
Pancreatitis is a rare complication of leptospirosis.19 
This patient presented epigastric pain and jaundice as the 
main manifestations of pancreatic involvement, and 
laboratory diagnosis could be achieved by the eleva-
tion of serum lipase levels of more than threefold the 
normal values and amylase levels more than four times 
of normal levels. There were no pancreatic morphologic 
changes detectable by ultrasound and abdominal CT ex-
amination revealed only intra-abdominal minimal fluid 
collection, with bilateral pleural effusion. The history of 
alcoholism may have mislead the etiology of pancreatitis 
in this case, but clinical features and leptospirosis serology 
confirmation weakened the suspicion of alcoholic pan-
creatitis. Other authors have described several cases of 
leptospirosis and pancreatitis diagnosed by elevated se-
rum amylase and lipase, but without morphologic change 
detectable by pancreatic ultrasound.9-14 Daher et al.17 
demonstrated that histopathological pancreatic changes 
are not well correlated with high level of serum amylase 
in human leptospirosis. So, the diagnosis of acute pancre-
atitis is somewhat controversial in this disease.19 Clinical 
symptoms of pancreatitis are not common findings and a 
true diagnosis of acute pancreatitis is complicated by the 
fact that acute renal failure, a leptospirosis usual manifes-
tation, can increase serum amylase and lipase levels.10 It 
is suggested that, apart from the typical clinical features, 
serum amylase levels higher than twice the normal value 
could not be explained only by renal failure.25 Therefore, 
in the presence of renal failure, Kishor et al.21 suggested 
laboratory diagnosis of acute pancreatitis should only be 
performed with amylase levels higher than 4.4 times the 
normal value. Sometimes, abdominal CT is essential for 
a correct diagnosis.
The patient reported here presented a favorable 
evolution, with total resolution of severe manifestations 
in a few weeks.
In conclusion, leptospirosis can be presented as a 
neurological primary disease. It should also be consid-
ered in the differential diagnosis of hyperamylasemia 
and jaundice in endemic areas. Clinicians need to be 
aware of the possibility of leptospirosis, even if the illness 
presents with unusual features, because early diagnosis 
and appropriate treatment is essential for life saving.
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